Rameda Pharmaceuticals
Yehia Amr Morsy is an experienced professional in the field of Human Resources and Organizational Development, currently serving as the Organizational Development and Strategic Planning Manager at Rameda Pharmaceuticals since October 2017, where previous roles included Associate Human Capital Manager and HR Business Partner. Prior to this, Morsy worked as a Human Resources Specialist at Concord Hotels for a brief period in 2017. Morsy's academic background includes a Bachelor's degree in Pharmacy from Pharos University in Alexandria, a Master's degree in Human Resources Management from the Arab Academy for Science, Technology and Maritime Transport, and ongoing doctoral studies in Business Administration with a focus on Human Resources Management and Services. Additional qualifications include an Associate's degree in Human Resources Management from HRCI, certification as a Personality Assessor from the MBTI Business Training Institute, and a diploma in Human Resources.
Rameda Pharmaceuticals
Our Vision: To become the most valuable emerging pharmaceutical company in Egypt. Our Mission: To provide our customers quality health care solutions in a cost effective manner by developing products and services that satisfy their health requirements. Establishment Rameda began operations in 1994 and was established by a group of Gulf investors with the intention of creating one of the largest pharmaceutical operations in the region. Owners hired V-Konsult of Germany to create a state-of-the art design. Contracted British Carter Construction company to build the Rameda’s facilities. Partnership with Alcon In 1999, Rameda entered into an agreement with Alcon to manufacture – under license - their ophthalmology products. In order to guarantee the quality of their products, Alcon built one of the highest quality eye production facilities in the region at Rameda. Quality enhancement Rameda renewed the syrup production to become GMP (Good Manufacturing Practice). A new Beginning In 2011, Compass Capital led a consortium of private equity investors for the acquisition of 100% of Rameda. Compass Capital plans to establish Rameda as a regional leader in the industry. To execute this strategy Rameda hired a new management team with a proven track record to complement the existing team. Company has commissioned M+W Group to transform solid dosage and beta lactam areas into GMP. Brining entire facility to compliance.